Congratulations to Professor Paul Emery OBE on being named CBE: Commander of the Most Excellent Order of the British Empire for his research and advances in rheumatology. He is the Versus Arthritis Professor of Rheumatology, Leeds Institute https://t.co/xeJu05q3q8 https://t.co/VvKmHHf0iv

• Colleagues celebrate New Year Honours

Dr. Sidney Wolfe, longtime US consumer health watchdog & advocate for affordable care & oversight of drug safety died on 1/1/24 of brain cancer at age 86. Dr. Wolf once ran the Health Research Group at Public Citizen, a Wash, DC consumer advocacy group https://t.co/e4lyDglx3n https://t.co/VyLMXJi4ZZ

• Sidney Wolfe, longtime US consumer health watchdog, dead at 86 By Reuters

Best of 2023: New ACR RA-ILD Treatment Guidelines – What Were They Smoking!? Rheumatoid arthritis related interstitial lung disease (RA-ILD) is common, with symptomatic RA-ILD affecting approximately 8% of RA patients. https://t.co/6RFBjVkmXj https://t.co/Qvquu7ruKY

• Best of 2023: New ACR RA-ILD Treatment Guidelines – What Were They Smoking!? | …

AutoAbs in poly/dermatomyositis - ANA+ 50% to 80%, but not helpful in Dx. Look for MSA Abs - espec antisynthetase ABs (anti-Jo-1), but also newer Abs: MDA-5, TIFF-1 gamma, NXP-2 (to be discussed #RNL24 Dr. Christopher-Stine) https://t.co/l46JHMWJby https://t.co/rZco5BMUJ5 https://t.co/2K9bidzLpt

• RheumaKnowledgy » Polymyositis/Dermatomyositis
• RN Live - RheumNow

Global temporal trends in MSK disorders in women of childbearing age increasing in138 countries, 24 decreasing & 42 w. flat trends. In 2019, the prevalence was 354 million w/ India, with China, USA, Indonesia & Brazil highest w/ 51% of global prevalence https://t.co/8nn4lTtNU2 https://t.co/BdkR3aXsZO

• Global, regional and national temporal trends in prevalence for musculoskeletal…

Best of 2023: Treatment and Management of Neuropsychiatric Lupus On the first day of ACR State of the Art conference in Orlando, Florida, Dr. Michelle Petri reviewed the treatment and management of neuropsychiatric lupus. https://t.co/0MXAtkDUmQ https://t.co/ZYuLniETnP

• Best of 2023: Treatment and Management of Neuropsychiatric Lupus | RheumNow

Best of 2023: Does Biologic Treatment in Psoriasis Reduce the Risk of Psoriatic Arthritis? https://t.co/9xn7lvxPiG https://t.co/PFYUISEKLe

• Best of 2023: Does Biologic Treatment in Psoriasis Reduce the Risk of Psoriatic…

FDA Approves the first Actemra biosimilar- called tocilizumab-bavi (Tofidence) or BIIB800 (during development). This IV FORMULATION is approved for use in active RA, polyarticular JIA and systemic JIA. https://t.co/XdQ3D2McTF https://t.co/wnusToyZTG https://t.co/w8ooCCGrI0…

• FDA Approves Biogen’s TOFIDENCE™ (tocilizumab-bavi), a Biosimilar Referencing A…
• FDA Approves First Tocilizumab Biosimilar for US Arthritis Patients
• t.co / Twitter

Could Methotrexate Work in Hand Osteoarthritis? Lancet reports the results of the METHODS study from Australia where hand osteoarthritis (HOA) patients benefitted from 6 months of methotrexate (MTX) - as long as there was MRI synovitis! https://t.co/TnvhGUiWuw https://t.co/FfnC63nBSa

• Could Methotrexate Work in Hand Osteoarthritis? | RheumNow

Full Read review of #PMR in Lancet: - Start @ 12·5–25mg prednisone qd - Remission in most but, relapses in 40–60% - Onset sudden; AM stiffness predominates; Shoulders>Pelvic ~50% have distal MSK Sxs - US: look for B/L sub-acromial/deltoid bursitis https://t.co/NwrbdMMdLU https://t.co/eRls0fLMJs

• Polymyalgia rheumatica

Gout Flare Prophylaxis - Colchicine or NSAIDs? A new study suggests that colchicine, more so than non-steroidal anti-inflammatory drug (NSAID) prophylaxis, may increase the odds of adverse events, when initiating allopurinol for gout. https://t.co/mZZxTIUeQq https://t.co/43COjhNXUf

• Gout Flare Prophylaxis - Colchicine or NSAIDs? | RheumNow

#RNL2023 Dr. Stanley Cohen: possible adverse effects of JAKi -Herpes zoster, other infections -Malignancy -Occasional cytopenias -LFTs (with DMARDs) -Incr Cr or CPK -Acne -Incr lipids -GI perf -VTE Which do you counsel with your patients? https://t.co/wOZh9qGQZD https://t.co/ODNcDHp1iU

• https://bit.ly/3RDmXcd